Inmune Bio, Inc. (35) | Uncategorized (12)
Recent Contracts
-
Form of Option Agreement between the Company and Non-Employee Directors and consultants
(Filed With SEC on March 24, 2022)
-
Form of Option Agreement for Employees of the Company
(Filed With SEC on March 24, 2022)
-
Description of Securities of INmune Bio, Inc
(Filed With SEC on March 3, 2022)
-
Amendment No. 1 to Rights Agreement, dated as of December 20, 2021, between INmune Bio Inc. and Vstock Transfer, LLC
(Filed With SEC on December 21, 2021)
-
Form of Option Agreement between the Company and Non-Employee Directors
(Filed With SEC on June 24, 2021)
-
Form of Option Agreement for Employees of the Company
(Filed With SEC on June 24, 2021)
-
Option Cancellation Agreement between INmune Bio Inc. and Xencor, Inc
(Filed With SEC on June 15, 2021)
-
Form of agreement between INmune Bio Inc. and National Securities Corporation, dated March 29, 2021
(Filed With SEC on March 29, 2021)
-
Rights Agreement, dated as of December 30, 2020, by and between INmune Bio Inc. and VStock Transfer, LLC
(Filed With SEC on January 4, 2021)
-
Rights Agreement, dated as of December 30, 2020, by and between INmune Bio Inc. and VStock Transfer, LLC
(Filed With SEC on December 30, 2020)
-
Award Agreement dated as of February 4, 2020
(Filed With SEC on February 10, 2020)
-
Award Letter dated as of February 22, 2019 from the Alzheimers Association to INmune Bio, Inc
(Filed With SEC on February 28, 2019)